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Article

MR1-restricted MAIT cells display ligand
discrimination and pathogen selectivity
through distinct T cell receptor usage
Marielle C. Gold,1,2,4 James E. McLaren,5 Joseph A. Reistetter,1
Sue Smyk-Pearson,1 Kristin Ladell,5 Gwendolyn M. Swarbrick,3
Yik Y.L.Yu,6 Ted H. Hansen,6 Ole Lund,7 Morten Nielsen,7,8 Bram Gerritsen,9
Can Kesmir,9 John J. Miles,5,10 Deborah A. Lewinsohn,2,3 David A. Price,5,11
and David M. Lewinsohn1,2,4

Mucosal-associated invariant T (MAIT) cells express a semi-invariant T cell receptor (TCR)
that detects microbial metabolites presented by the nonpolymorphic major histocompatibility
complex (MHC)–like molecule MR1. The highly conserved nature of MR1 in conjunction with
biased MAIT TCR chain usage is widely thought to indicate limited ligand presentation and
discrimination within a pattern-like recognition system. Here, we evaluated the TCR repertoire of MAIT cells responsive to three classes of microbes. Substantial diversity and heterogeneity were apparent across the functional MAIT cell repertoire as a whole, especially for
TCR chain sequences. Moreover, different pathogen-specific responses were characterized
by distinct TCR usage, both between and within individuals, suggesting that MAIT cell adaptation was a direct consequence of exposure to various exogenous MR1-restricted epitopes.
In line with this interpretation, MAIT cell clones with distinct TCRs responded differentially
to a riboflavin metabolite. These results suggest that MAIT cells can discriminate between
pathogen-derived ligands in a clonotype-dependent manner, providing a basis for adaptive
memory via recruitment of specific repertoires shaped by microbial exposure.
CORRESPONDENCE
Marielle C. Gold:
goldm@ohsu.edu
OR
David M. Lewinsohn:
lewinsod@ohsu.edu
Abbreviations used: MAIT,
mucosal-associated invariant T;
MOI, multiplicity of infection;
Mtb, Mycobacterium tuberculosis.

Mucosal-associated invariant T (MAIT) cells are
characterized by the expression of a semi-invariant
TCR that engages antigenic ligands restricted
by the nonpolymorphic MHC-like molecule
MR1. Human MAIT TCRs typically comprise
a TRAV1-2/TRAJ33 gene–encoded  chain
paired with a  chain constructed from TRBV20-1
or TRBV6 family gene segments (Porcelli et al.,
1993; Tilloy et al., 1999; Reantragoon et al., 2013).
In contrast to conventional  T cell populations, pathogen-reactive MAIT cells with effector
M.C. Gold and J.E. McLaren contributed equally to this paper.
D.A. Price and D.M. Lewinsohn contributed equally to
this paper.
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capacity can be found in the human thymus
(Gold et al., 2013). Moreover, their selection
depends on hematopoietic cells rather than
thymic epithelium (Treiner et al., 2005; Martin
et al., 2009). Collectively, these attributes suggest
that MAIT cells constitute an innate T cell subset
with conserved recognition properties.
Despite these innate-like features, several lines
of evidence support the hypothesis that pathogenreactive MAIT cells adapt to their environment.
© 2014 Gold et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months
after the publication date (see http://www.rupress.org/terms). After six months
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/
licenses/by-nc-sa/3.0/).
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Table 1.

Summary of TCR usage in human MAIT cell clones
TRBV

TRAJ

CDR3

D470_B1a

20-1
4-2
6-4
6-4
6-4
6-4
6-4
6-4
20-1
20-1
20-1
6-2/3
6-4
6-5
6-6
17

20
20
20
20
33
33
33
33
33
33
33
33
33
33
33
33

CAVNGDDYKLSF
CAVRDSDYKLSF
CAVSLQDYKLSF
CAVRDGDYKLSF
CAVRDSNYQLIW
CAVRDSNYQLIQW
CAVRDSNYQLIQW
CAVRDSNYQLIW
CAAMDSNYQLIW
CAAMDSNYQLIW
CAVLDSNYQLIW
CARSDSNYQLIW
CAVMDSNYQLIW
CAVSDSNYQLIW
CAALDSNYQLIW
CASMDSNYQLIW

D481_F12
D481_C7
D571_A1
D426_G11
D426_B1a
D466_F5a
D571_A10-2
D481_A9
D504_F9-2
D466_A3
D450_C8a
D426_A6
D426_G1
D470_F6
D504_H11

Putative TCR families appear in bold and italics.
aPreviously described in Gold et al. (2010).

It is established that MAIT cells detect a broad range of microorganisms (Gold et al., 2010; Le Bourhis et al., 2010) and
contribute to the control of several pathogens in mice, including Klebsiella pneumoniae (Georgel et al., 2011), Francisella
tularensis (Meierovics et al., 2013), and mycobacterial species
(Le Bourhis et al., 2010; Chua et al., 2012). Furthermore,
MAIT cells expand in the periphery after thymic egress as a
consequence of microbial colonization (Martin et al., 2009;
Le Bourhis et al., 2010). In line with these observations,
human MAIT cells display a naive phenotype in cord blood
but acquire characteristics associated with exogenous antigen
exposure in adults (Dusseaux et al., 2011; Gold et al., 2013).
However, the microbial and environmental signals that lead to
the migration, differentiation, expansion, and maintenance of
MAIT cells are not understood.
Although the MAIT TCR has been described as semiinvariant, there is sufficient plasticity within the repertoire to
allow for the possibility of diverse ligand recognition. Indeed,
MAIT TCRs are not exclusively germline-encoded and incorporate sequence variability as a consequence of V(D)J
recombination (Tilloy et al., 1999; Greenaway et al., 2013;
Reantragoon et al., 2013). This process of somatic gene rearrangement potentially enables pathogen-specific recognition
within the confines of restricted TCR gene usage.
Recently, MR1 has been shown to bind small organic
compounds derived from microbial vitamin B biosynthetic
pathways (Kjer-Nielsen et al., 2012). Although MR1 binds
metabolites of vitamin B9 (folic acid), only three derivatives of
vitamin B2 (riboflavin), rRL-6-CH2OH, RL-6-Me-7-OH,
and RL-6,7-diMe, are known to stimulate MAIT cells (KjerNielsen et al., 2012). Consistent with this observation, microorganisms with the capacity to synthesize riboflavin have been
associated with MAIT cell activation (Gold et al., 2010;
1602

RESULTS
The TCR repertoire of MAIT cells identified using an MR1
tetramer loaded with the stimulatory vitamin B metabolite,
rRL-6-CH2OH, was recently shown to be more heterogeneous than expected based on previous studies (Reantragoon
et al., 2013). Moreover, MAIT cells can detect infection with
a wide range of bacteria and fungi (Gold et al., 2010;
Le Bourhis et al., 2010), which likely have diverse metabolic
pathways. In this context, we aimed to determine the relationship between TCR usage and pathogen discrimination.
In earlier work, we used limiting dilution analysis to
generate a panel of Mycobacterium tuberculosis (Mtb)–reactive
CD8+ MAIT cell clones (Gold et al., 2010). All of these
clones expressed TRAV1-2+ TCRs and recognized Mtb-infected cells in an MR1-restricted manner as determined by
V7.2-specific mAb staining and functional blockade with an
MR1 mAb, respectively (not depicted; Gold et al., 2010).
Sequence analysis confirmed this finding and further revealed
that the majority of clones also incorporated the canonical
TRAJ33 gene segment (Table 1). However, 4/16 clones expressed TRAJ20 (Gold et al., 2010), suggesting that pathogenreactive MAIT cells could yield additional TCR specificities.
Moreover, we observed that MAIT cells from different individuals segregated into TCR families through preferential
pairing of specific TCR and TCR chains (Table 1). For
example, clones A9 and F9-2 from donors 481 and 504, respectively, expressed identical TRAV1-2/TRAJ33+  chains
paired with TRBV20-1+  chains.
To extend these findings beyond the Mtb-specific setting,
we used an unbiased molecular approach to evaluate the MAIT
TCR repertoire across diverse bacterial and fungal species.
Peripheral blood CD8+ T cells from four unrelated adult
donors were stimulated directly ex vivo by exposure to A549
epithelial cells infected with M. smegmatis, S. typhimurium, or
C. albicans to identify pathogen-reactive MAIT cells restricted by
MR1 (Gold et al., 2010, 2013). Functionally responsive MAIT
MAIT cells display pathogen selectivity | Gold et al.
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Clone ID

Le Bourhis et al., 2010; Kjer-Nielsen et al., 2012). However,
structural studies have revealed that MR1 is promiscuous in
its ability to bind and present diverse ligands (Reantragoon et al.,
2012; López-Sagaseta et al., 2013a; Patel et al., 2013). Accordingly, there may be discrete pathogen-associated ligands that
are yet to be identified.
In this study, we evaluated the ex vivo TCR repertoire
of pathogen-reactive MAIT cells responsive to Mycobacterium
smegmatis, Salmonella typhimurium, and Candida albicans. Clonotype usage was complex and highly selective within individuals, suggesting a diverse array of MR1-restricted microbial
ligands. Moreover, different pathogen-specific responses were
characterized by distinct TCR repertoires, both between and
within individuals. Direct evidence of MR1-restricted ligand
discrimination at the clonal level further supported the potential for unique patterns of pathogen recognition by MAIT
cells. Collectively, these data provide a basis for specific TCR
repertoire mobilization within an innate-like system shaped
by previous microbial exposure.
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cells were isolated for repertoire experiments at high purity using
a flow cytometric sorting strategy to detect viable TRAV1-2+
cells expressing TNF (Haney et al., 2011). Response sizes varied from 0.5 to 6.9% of the TRAV1-2+ CD8+ T cell population
with no significant differences between pathogens. Clonotypic
analysis was then performed using a template switch–anchored
RT-PCR as described previously (Quigley et al., 2011).
An aggregated analysis of TRAJ gene usage by pathogenreactive TRAV1-2+ MAIT TCRs is shown in Fig. 1. Although
the canonical TRAV1-2/TRAJ33 rearrangement dominated the
TCR chain repertoire, alternative TRAJ genes were commonly
used. In particular, substantial proportions of the TRAV1-2/nonTRAJ33 rearrangements incorporated TRAJ20 or TRAJ12 segments. Moreover, an array of TRAJ genes not previously known
to associate with pathogen-reactive,TRAV1-2+ MAIT cells were
JEM Vol. 211, No. 8

Figure 2. Pathogen-reactive MAIT TCR chains are diverse. Details
as described in the legend to Fig. 1, except that TRBV gene usage was analyzed. Aggregate TRBV gene profiles from all four donors in response to
each pathogen (n = 3) are shown at the top; data from individual donors
are shown underneath as indicated. Each sequence was counted once regardless of frequency. Total sequence counts are indicated in each case.

identified. Of these noncanonical genes, TRAJ9 and TRAJ39 do
not encode the Tyr95 residue present in TRAJ33,TRAJ20, and
TRAJ12 (Reantragoon et al., 2013), which is thought to be critical for MAIT cell activation (Reantragoon et al., 2012; Patel et al.,
2013;Young et al., 2013). Due to the lack of allelic exclusion at the
TRA locus, however, we cannot definitively assign these  chains
to functional heterodimeric TCRs.
Notable differences in TRAJ gene usage were apparent
across pathogen-reactive MAIT cell populations. In terms of
overall distribution, diversity was greatest for S. typhimurium
and most restricted for C. albicans. Individual TRAJ gene usage
also differed across specificities within each individual. This
was most striking in donor 520 (D520). Here, TRAV1-2/
TRAJ33 gene–encoded TCRs were elicited in response to
M. smegmatis and S. typhimurium, but not in response to C. albicans. Collectively, these data demonstrate that pathogen-reactive
TRAV1-2+ MAIT cells can productively incorporate a broad
array of TRAJ gene segments with differential usage across
pathogen specificities.
1603

Downloaded from jem.rupress.org on August 16, 2014

Figure 1. Pathogen-reactive MAIT TCR chains are not confined
to TRAV1-2/TRAJ33 rearrangements. Human CD8+ MAIT cells from
four individuals were stimulated overnight using A549 cells infected with
M. smegmatis, S. typhimurium, or C. albicans. Live, pathogen-reactive
MAIT cells were then isolated by flow cytometry based on coexpression of
TRAV1-2 and TNF. Unbiased molecular analysis of expressed TRA gene
products was performed as described in Materials and methods. Aggregate TRAJ gene profiles from all four donors in response to each pathogen (n = 3) are shown at the top; data from individual donors are shown
underneath as indicated. Each sequence was counted once regardless of
frequency. Total sequence counts are indicated in each case.

Published July 21, 2014

A similar analysis is shown for TRBV gene usage in Fig. 2.
Across the dataset as a whole, 35 different TRBV genes were
represented within the pathogen-reactive MAIT cell repertoire. Most frequent among these were the TRBV20-1 and
TRBV6 family gene members. In contrast, these TRBV genes
were used by <6% of nonresponsive TRAV1-2+ cells, which
1604

expressed a diverse array of TRBV genes without apparent enrichments (not depicted). As above, TRBV gene usage was most
diverse for S. typhimurium and varied across specificities within
each individual. In D520, for example, the MAIT cell response
to C. albicans was composed entirely of TRBV20-1+ TCRs,
yet these were relatively rare in the corresponding responses
MAIT cells display pathogen selectivity | Gold et al.
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Figure 3. MAIT TRAV1-2+ CDR3 sequences
display length and sequence similarity. (A) Representation of unique TRAV1-2+ CDR3 sequences from each donor in response to each
pathogen as indicated. Each bar represents a
distinct sequence, the relative frequency of which
is depicted on the y axis. TRAJ gene usage is
shown on the x axis labeled for dominant sequences. (B) Distribution of CDR3 amino acid
lengths from TRAV1-2+ MAIT cells responsive to
each pathogen as indicated in the key. (C) Visual
representation of amino acid enrichments at each
position across the CDR3 core compiled from
pathogen-reactive MAIT cell TRAV1-2+ sequences.
Analysis was confined to CDR3 sequences with
a length of 11 amino acids, encompassing 39
sequences for M. smegmatis, 61 for S. typhimurium,
and 30 for C. albicans. Graphics were generated
using Seq2Logo.
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Table 2. Similarity analyses of TRAV1-2+ CDR3 sequences
Group 1

Group 2

(A) Similarity analysis across individuals
D497
D497
D497
D518
D497
D520
D497
D674
D518
D497
D518
D518
D518
D520
D518
D674
D520
D497
D520
D518
D520
D520
D520
D674
D674
D497
D674
D518
D674
D520
D674
D674
(B) Similarity analyses across pathogens
C. albicans
C. albicans
C. albicans
S. typhimurium
C. albicans
M. smegmatis
S. typhimurium
C. albicans
S. typhimurium
S. typhimurium
S. typhimurium
M. smegmatis
M. smegmatis
C. albicans
M. smegmatis
S. typhimurium
M. smegmatis
M. smegmatis

Similarity
0.947
0.940
0.935
0.942
0.899
0.912
0.901
0.905
0.858
0.866
0.903
0.861
0.906
0.913
0.907
0.923
0.934
0.925
0.927
0.896
0.906
0.902
0.901
0.910
0.916

Bolded values denote those with the highest similarity within each comparison group.

chains can discriminate between ligands. Although we have
no knowledge of each individual’s microbial exposure history,
the repertoire observed for any particular microbial pathogen
may reflect prior ligand exposure. At present, the precise nature of such MR1-restricted antigens and their relationship to
TCR usage remains unknown.
To assess true clonotypic diversity, we similarly evaluated
TCR chain usage across donors and specificities (Fig. 4). For
this purpose, we selected TRBV20-1+ sequences, which represent the most common TRBV gene–defined clonotypes across
pathogen-reactive MAIT cells. As above, unique TRBV20-1+
sequences were associated with each pathogen specificity. In
D497, for example, MAIT cell populations specific for S. typhimurium and C. albicans incorporated different CDR3 loops
despite equivalent TRBV20-1 gene usage (Fig. 4 A); these
sequences were further distinct from those responsive to M.
smegmatis (Fig. 4 A). Similar findings applied to other TRBV
gene families (not depicted). Moreover, across the entire dataset, only four shared TCR clonotypes were detected between
donors; notably, each of these sequences was associated with
more than one pathogen specificity (not depicted). Thus, in
sharp contrast to the TCR chain repertoire, minimal TCR
overlap was present across donors and pathogens.
1605
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to S. typhimurium and M. smegmatis. Thus, MAIT cells use diverse TRBV gene segments with variable clonotypic deployment across pathogen specificities.
Previous studies have demonstrated that MAIT TCR
chains are not exclusively germline encoded (Tilloy et al.,
1999; Treiner et al., 2005; Gold et al., 2010; Goldfinch et al.,
2010) and most often contain single nucleotide additions that
contribute to CDR3 core diversity (Greenaway et al., 2013).
We therefore performed an in-depth analysis of CDR3 sequences across our dataset (Fig. 3).
Unique CDR3 sequences within the TRAV1-2+ repertoire are displayed across donors and specificities in Fig. 3 A.
In these graphics, each bar represents a distinct sequence plotted as a function of TRAJ gene usage (x axis) and relative frequency (y axis). Disparate patterns were observed, suggesting
pathogen-specific MAIT cell reactivity. In D497, for example, M.
smegmatis and C. albicans elicited three predominant TRAV1-2+
sequences that were distinct from one another; a broader repertoire was activated in response to S. typhimurium, which
again differed at the level of CDR3 sequence usage. Similarly, the TRAV1-2+ MAIT cell response to C. albicans was dominated by two unique sequences in D520, whereas broader
repertoires were elicited by M. smegmatis and S. typhimurium.
Thus, the MAIT cell response to each of these microbes was
characterized by unique TCR usage within individuals.
Although no unique TRAV1-2+ sequence appeared to
associate with a single pathogen or a single donor, we wanted
to evaluate patterns of amino acid usage across pathogen specificities. To perform this analysis on the greatest number of
TRAV1-2+ transcripts, we selected CDR3 sequences con
taining 11 amino acid residues (Fig. 3 B).This subset contained
39 sequences for M. smegmatis, 61 for S. typhimurium, and 30
for C. albicans. Representative logos highlighting preferential
amino acid usage for each pathogen are shown in Fig. 3 C.
Particular amino acid motifs were prevalent within the TRAV1-2+
sequences for each pathogen. For example, tyrosine (Y) was
highly prevalent at position 8 in C. albicans–reactive MAIT
cells, whereas glycine (G) was favored at position 7 for S. typhimurium. To quantify this observation further, we compared
the similarity of TRAV1-2+ sequences within a given group,
defined by donor or pathogen, to the corresponding sequence
similarity between groups (Shen et al., 2012). The analysis
across donors shown in Table 2 (A) demonstrates two points.
First, overall similarity is high, given that a value of 1 represents 100% similarity. Second, similarity within each donor is
consistently greater than the similarity between donors. Similar
patterns were observed across pathogen specificities (Table 2, B).
The significance of these analyses was evaluated using an
exact permutation test. Here, each observed TRAV1-2+ sequence was randomly assigned to a donor-pathogen pair to
determine whether such associations could lead to a result
where the similarity within donors and pathogens (intrasimilarity) was consistently higher than the similarity between
donors and pathogens (intersimilarity). None of the permutations across 1,000 rounds resulted in higher intersimilarity
(P < 0.001). Collectively, these data suggest that MAIT TCR

Published July 21, 2014

To evaluate amino acid usage across specificities, we selected
all clonotypes with CDR3 sequences containing 13 or 14
residues, based on prevalence within the length distribution
profile (Fig. 4 B). This subset contained 34 sequences for
M. smegmatis, 75 for S. typhimurium, and 39 for C. albicans. No
obvious motifs were present across the CDR3 core, although
1606

TRBJ gene–encoded phenylalanine (F) and tyrosine (Y) residues were notably represented at the C terminus, potentially
reflecting amino acid conservation linked to preferential usage
of TRBJ1-1, TRBJ2-1, and TRBJ2-7 (Fig. 4 C). To extend
these observations, we performed similarity analyses for the
most common TRBV gene–defined clonotypes in our dataset
MAIT cells display pathogen selectivity | Gold et al.
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Figure 4. MAIT CDR3 usage is unique
across individuals and pathogens. (A) Representation of unique TRBV20-1+ CDR3 sequences
from each donor in response to each pathogen as
indicated. Each bar represents a distinct sequence,
the relative frequency of which is depicted on the
y axis. TRBJ gene usage is shown on the x axis
labeled for dominant sequences. (B) Distribution
of CDR3 amino acid lengths from all TRBV
gene–defined MAIT cells responsive to each
pathogen as indicated in the key. (C) Visual representation of amino acid enrichments at each
position across the CDR3 core compiled from
pathogen-reactive MAIT cell TRBV+ sequences.
Analysis was confined to CDR3 sequences with
a length of 13 or 14 amino acids, encompassing
34 sequences for M. smegmatis, 75 for S. typhi
murium, and 39 for C. albicans. Graphics were
generated using Seq2Logo.
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DISCUSSION
In this study, we evaluated the ex vivo TCR repertoire of
MAIT cells responsive to three distinct classes of pathogens.
Substantial diversity and heterogeneity were apparent across
the functional MAIT cell repertoire as a whole, especially for
TCR chain sequences. Moreover, different pathogen-specific
responses were characterized by distinct TCR usage, both
between and within individuals, suggesting that MAIT cell
adaptation was a direct consequence of exposure to various
exogenous MR1-restricted epitopes. In line with this interpretation, MAIT cell clones with distinct TCRs responded
differentially to a riboflavin metabolite. These results suggest
that MAIT cells can discriminate between pathogen-derived
ligands in a clonotype-dependent manner, potentially enabling
adaptive memory within a pattern-like recognition system.
MAIT cells were originally defined by the expression of a
canonical semi-invariant TRAV1-2/TRAJ33 TCR chain
JEM Vol. 211, No. 8

Table 3. Similarity analyses of TRBV6-1+, TRBV6-2/3+,
TRBV20-1+, and TRBV28+ CDR3 sequences
Group 1

Group 2

Similarity

(A) Similarity analyses across individuals
D497
D497
0.858
D497
D518
0.840
D497
D520
0.838
D497
D674
0.852
D518
D497
0.852
D518
D518
0.859
D518
D520
0.838
D518
D674
0.849
D520
D497
0.841
D520
D518
0.830
D520
D520
0.850
D520
D674
0.837
D674
D497
0.849
D674
D518
0.837
D674
D520
0.833
D674
D674
0.858
(B) Similarity analyses across pathogens
C. albicans
C. albicans
0.861
C. albicans
S. typhimurium
0.855
C. albicans
M. smegmatis
0.842
C. albicans
0.853
TRAV1-2+ TNF
S. typhimurium
C. albicans
0.842
S. typhimurium
S. typhimurium
0.855
S. typhimurium
M. smegmatis
0.838
S. typhimurium
0.847
TRAV1-2+ TNF
M. smegmatis
C. albicans
0.843
M. smegmatis
S. typhimurium
0.853
M. smegmatis
M. smegmatis
0.869
0.848
M. smegmatis
TRAV1-2+ TNF
(C) Similarity analyses across nonreactive (TNF) and pathogenreactive (TNF+) subsets
M. smegmatis
0.844
TRAV1-2+ TNF
S. typhimurium
0.857
TRAV1-2+ TNF
C. albicans
0.845
TRAV1-2+ TNF
0.858
TRAV1-2+ TNF
TRAV1-2+ TNF
Bolded values denote those with the highest similarity within each comparison group.

(Porcelli et al., 1993; Tilloy et al., 1999). Additional TCR
complexity was subsequently demonstrated in Mtb-reactive
MAIT cell clones (Gold et al., 2010) and more recently in
rRL-6-CH2OH/MR1 tetramer–reactive cells (Reantragoon
et al., 2013). In line with the latter study, pathogen-reactive
MAIT cells frequently expressed TRAJ33, TRAJ12, and
TRAJ20 gene transcripts. Each of these genes encodes the
Tyr95 residue thought to be essential for MR1-restricted ligand recognition (Reantragoon et al., 2012; López-Sagaseta
et al., 2013a; Patel et al., 2013). Our study identifies two additional TRAJ genes, namely TRAJ41 and TRAJ28, which also
encode Tyr95 in MAIT cells. Further TRAJ gene transcripts,
1607
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(TRBV20-1, TRBV6-1, TRBV6-2/3, and TRBV28), comprising a total of 148 unique sequences across all donors and
pathogens (Table 3, A and B). Again, the similarity indices
were consistently high, but nevertheless lower than for the
TRAV1-2+ sequences, reflecting a more diverse TCR repertoire. Furthermore, intrasimilarity was significantly greater
than intersimilarity for all TRBV gene–defined comparison
groups across donors (Table 3, A) and pathogens (Table 3, B).
This latter observation is particularly remarkable in the case
of S. typhimurium, which mobilized a highly diverse set of
TCR clonotypes (median Simpson’s diversity index, 0.934–
0.983) compared with M. smegmatis and C. albicans (median
Simpson’s diversity index, 0.221/0.184 to 0.971/0.966, respectively). Finally, we compared the similarity of TRBV
gene–defined sequences in TRAV1-2+ nonreactive (TNF)
cells isolated during the C. albicans stimulation protocol with
the corresponding pathogen-reactive (TNF+) populations.
The greatest level of similarity was observed among the nonreactive TRAV1-2+ cells (Table 3, C). Collectively, these analy
ses support the conclusion that different pathogen-associated
antigens drive distinct donor-specific TCR clonotype expansions within the MAIT cell population.
To confirm this hypothesis, we tested four TCR-distinct
MAIT cell clones (Table 1; Gold et al., 2010) for reactivity against
the riboflavin-derived MR1-restricted ligand RL-6,7-diMe
(Kjer-Nielsen et al., 2012) in IFN- ELISPOT assays. Only
two clones recognized RL-6,7-diMe (Fig. 5 A), even though
all four were comparably stimulated by presenting cells infected with M. smegmatis. The stronger agonist rRL-6-CH2OH
was not tested (Kjer-Nielsen et al., 2012; Corbett et al., 2014).
Moreover, each clone responded similarly to each of the three
pathogens used for TCR analysis (Fig. 5 B). Notably, all four
clones contain the Tyr95 residue thought to be essential for
MR1-restricted recognition (Reantragoon et al., 2012; Patel
et al., 2013; Young et al., 2013). Nevertheless, this character
istic in isolation was not sufficient for universal activation by
RL-6,7-diMe. Thus, MAIT cells can discriminate between
MR1-restricted ligands.
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such as TRAJ9 and TRAJ39, were detected that do not encode Tyr95. In one donor (D520), these two genes dominated TRAJ usage in MAIT cells responsive to C. albicans, but
not M. smegmatis or S. typhimurium, suggesting alternative modes
of TCR engagement. However, the lack of allelic exclusion
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Figure 5. MR1-restricted MAIT cell clones display ligand discrimination for the vitamin B metabolite RL-6,7-diMe. (A) A549 cells
(20,000 per well) were pulsed with 5 µg/ml RL-6,7-diMe overnight and
tested for their ability to stimulate MR1-restricted clones (10,000 per
well) in IFN- ELISPOT assays. Clones D426 B1 and D481 A9 express
TRAJ33; clones D481 F12 and D481 C7 express TRAJ20. TRBV usage and
CDR3 and CDR3 sequences are indicated. Error bars represent SEM of
duplicate determinations. (B) A549 cells (25,000 per well) were infected
with S. typhimurium, C. albicans, or M. smegmatis at an MOI of 50 (hi), 25
(med), or 12.5 (lo) and then incubated overnight with the indicated MR1restricted MAIT cell clones (10,000 per well) in duplicate wells. IFN- production was quantified by ELISPOT. Similar results were obtained from a
minimum of three independent experiments.

at the TRA locus precludes definitive conclusions. Nonetheless, the TCR repertoire of MAIT cells is clearly more diverse than previously described and shows features consistent
with pathogen selectivity.
Historically, MAIT cells have been associated with
TRBV20-1 and TRBV6 family genes (Porcelli et al., 1993;
Tilloy et al., 1999). More recently, 75% of tetramer-reactive
MAIT cells were found to express these TRBV genes despite
the presence of additional heterogeneity (Reantragoon et al.,
2013). Although pathogen-reactive MAIT cells frequently
displayed TRBV20-1 and TRBV6 family gene usage in our
study, >50% of all TRBV family genes were also detected, revealing greater heterogeneity than observed previously. These
findings could indicate promiscuous pairing or the potential
for diverse ligand recognition mediated by the TCR chain.
The extent to which the TCRV domain contributes to ligand discrimination remains unclear. Mutagenesis of specific
residues in the CDR3 loop did not alter MAIT hybridoma
cell recognition of MR1-overexpressing cells loaded with Sal
monella supernatants; however, TCRV chain swapping abrogated recognition by the same hybridoma (Reantragoon et al.,
2012). These data suggest that the TCRV domain contributes to MR1-restricted ligand recognition in ways that remain
to be defined. At present, our ex vivo analysis of pathogenreactive MAIT cells precludes the assignment of  pairing.
Nonetheless, limited analysis of Mtb-reactive clones points to
segregation of MAIT cells into TCR families through preferential pairing of specific TCR and TCR chains. For example, MAIT cell clones with identical CDR3 chains
isolated from different individuals tended to associate with
the same TRBV gene family. Such putative TCR families
may, at least in theory, contribute to greater affinities for specific classes of antigen. Indeed, the observation that only four
TCR sequences were shared across our entire dataset suggests that clonotypic expansions occur in a manner similar to
conventional T cells. Accordingly, the observation of unique
TRBV gene usage across pathogens suggests that TCR
chains contribute to ligand detection. This conclusion is supported by molecular analyses of MAIT TCR engagement
with MR1-presented ligands (Reantragoon et al., 2012;
López-Sagaseta et al., 2013a,b; Patel et al., 2013;Young et al.,
2013), which have revealed a docking mode similar to that of
classical MHC-restricted  TCRs and unlike that used by
CD1-restricted iNKT cells (Reantragoon et al., 2012; LópezSagaseta et al., 2013a,b; Patel et al., 2013). In this case, the less
variable TCR chain primarily mediates contacts with the
MR1 protein, whereas the CDR3 loop is positioned above
the MR1 ligand–binding groove. As suggested previously
(López-Sagaseta et al., 2013a,b), this topography lends itself
to the interpretation that the CDR3 loop can contribute to
ligand discrimination.
Based on our findings, we postulate that MR1-restricted
ligand diversity drives MAIT cell adaptation and TCR repertoire diversity. Although not yet described, we presume that the
naive MAIT thymocyte population contains a diverse and unfocused precursor repertoire. Subsequently, skewed clonotypic
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MATERIALS AND METHODS
Human subjects. All samples were collected under protocols approved by
the Institutional Review Board at Oregon Health and Science University.
PBMCs were obtained by apheresis from healthy adult donors with informed
consent. Subjects lacked any detectable responses to the immunodominant
Mtb antigens CFP-10 and ESAT-6 and were considered unexposed. Exposure to M. smegmatis, S. typhimurium, and C. albicans was not evaluated.
Cells and reagents. A549 cells (ATCC CCL-185) were used as stimulators
for direct ex vivo determination of Mtb-reactive T cells. Mtb-specific MAIT
cell clones were generated, maintained, and tested by IFN- ELISPOT as
described previously (Gold et al., 2010). All of these clones expressed TRAV12+ TCRs and recognized pathogen-infected cells in an MR1-restricted manner. RL-6,7-diMe was purchased from WuXi AppTec.
JEM Vol. 211, No. 8

Microorganisms and infection of A549 cells. Adherent A549 cells were
infected overnight with M. smegmatis (multiplicity of infection [MOI] 10),
and nonadherent A549 cells were infected for 1 h with S. typhimurium (MOI
30) or C. albicans (MOI 3) at 37°C. All infections were performed in the absence of antibiotics.
Stimulation and isolation of pathogen-reactive MAIT cells. CD8+
T cells were enriched from PBMCs by negative selection using magnetic bead
separation according to the manufacturer’s instructions (STEMCELL Technologies), added to uninfected or infected A549 cells at a ratio of 3:1, and incubated for 16 h in the presence of -TNF (Beckman Coulter) and TAPI-O
(EMD Millipore) to prevent TNF cleavage from the cell surface (Haney et al.,
2011). The following day, cells were stained with: (a) -CD4 and -CD8
(BioLegend) and (b) –TRAV1-2 and –TCR (Thermo Fisher Scientific). Dead cells were excluded from the analysis using propidium iodide
(BioLegend).Viable CD4TCRCD8+TRAV1-2+TNF+ cells were sorted
at high purity using a FACSAria flow cytometer (BD) directly into RNAlater (Applied Biosystems). The corresponding nonfunctional populations
were sorted in parallel for control purposes. In all cases, cell numbers were
standardized (5,000 per aliquot) to minimize sampling bias.
Molecular analysis of TCR usage. Clonotypic analysis of sorted cell populations was performed as described previously (Quigley et al., 2011). In brief,
unbiased amplification of all expressed TRB or TRA gene products was
conducted using a template switch–anchored RT-PCR with chain-specific
constant region primers. Amplicons were subcloned, sampled, sequenced, and
analyzed as described previously (Price et al., 2005). The IMGT nomenclature is used in this study (Lefranc et al., 2003).
Construction of sequence logos. Sequence logos were generated in
Shannon format without the use of pseudo counts via the Seq2Logo webserver (Thomsen and Nielsen, 2012). Shannon sequence logos give a visual
representation of amino acid enrichments at different positions in the observed CDR3 sequences. The different amino acids are colored according to
physicochemical properties (acidic [DE], red; basic [HKR], blue; hydrophobic [ACFILMPVW], black; and neutral [GNQSTY], green). For TRAV1-2,
only sequences with a length of 11 amino acids were included (39 sequences
for M. smegmatis, 61 for S. typhimurium, and 30 for C. albicans). For TRBV, only
sequences with a length of 13 or 14 amino acids were included (34 sequences
for M. smegmatis, 75 for S. typhimurium, and 39 for C. albicans). The TRBV
sequences were aligned using ClustalX (Larkin et al., 2007) with default
parameters set before logo generation.The width of each bar in the sequence
logo corresponds inversely with gap density at the given positions.
CDR3 sequence similarity. Similarity between CDR3 sequences was
calculated as described previously (Shen et al., 2012). This method allows
similarities to be assigned between sequences of different length in an alignment-free manner. In this similarity measure, a perfect match has a similarity
score of 1, and a perfect mismatch has a similarity score of 0. To calculate the
similarity between two groups of sequences, each sequence from the first
group was assigned a score corresponding to the best match against all sequences from the other group (excluding identical matches), and the similarity between the two groups was calculated as the mean of these similarity
measures over all sequences within the first group.
CDR3 sequence diversity. Simpson’s diversity index was calculated using
the randomization method as described previously (Venturi et al., 2007).The
median value for each population was derived from 10,000 random draws
standardized to the lowest sample size.
We thank Erin Merrifield for expert assistance with human subject protocols.
This work was supported by the Department of Veterans Affairs with resources
and facility access provided by the Portland VA Medical Center, the National
Institutes of Health (NIH) via the Mucosal Immunology Studies Team (MIST) U01
AI095776-01 funded by the National Institute of Allergy and Infectious Diseases
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responses to different pathogens emerge in the periphery as a
result of antigenic exposure to a diverse array of MR1-restricted
ligands. We further propose that these expansions will reflect
distinct microbial challenges.This scenario of differential agonist encounter would explain the unique clonotypic expansions across individuals with different microbial exposure
histories. In line with this hypothesis, increased MAIT TCR
engagement through the CDR3 loop was recently associated with greater MR1-restricted ligand potency (LópezSagaseta et al., 2013b; Patel et al., 2013). Thus, patterns of
clonotypic expansion are likely to reflect high-affinity TCR
interactions with distinct MR1 ligands, consistent with previous observations in conventional systems (Price et al., 2005).
Although the possibility exists that stimulatory micro
organisms express the same few MR1-restricted riboflavin ligands in different proportions, elegant molecular analyses provide
evidence that MR1 can accommodate a range of different ligands (Reantragoon et al., 2012; López-Sagaseta et al., 2013a;
Patel et al., 2013).To date, only three MAIT cell epitopes have
been identified, all of which are riboflavin metabolites (KjerNielsen et al., 2012; Reantragoon et al., 2012, 2013; Patel
et al., 2013). Nonetheless, these antigens share many chemical
properties with other microbial and mammalian compounds.
It is therefore highly feasible that other MR1-restricted ligands
are generated similarly, enabling MAIT cell adaptation to a wide
range of microorganisms and their associated metabolomes.
Pathogen-reactive MAIT cells share many features traditionally thought to be associated with both innate and adaptive
T cells. Restriction by a nonpolymorphic MHC-like molecule, expression of a semi-invariant TCR, thymically acquired
effector function, and intrathymic selection by hematopoietic
cells are all considered features of innate T cells. However,
after thymic egress, MAIT cells expand and acquire an effector
phenotype associated with antigenic exposure. Furthermore, the
development of MAIT cells requires the presence of bacteria,
suggesting the capacity to adapt in response to environmental
signals. Our data provide evidence that MAIT cells can detect
a diverse array of MR1-restricted ligands and differentiate selectively in response to specific pathogens akin to classically
restricted T cells. Thus, the MAIT TCR enables adaptive immune responses within the confines of a pattern-like recognition system that can discriminate between microorganisms.
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